Soligenix (SNGX) Advances CTCL Research With Interim Analysis, Comparative Study Results

Advancing clinical research while generating positive data is a critical combination in biotechnology, particularly when ...
Santé log

Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds

In a 12‑week comparative study, Omada GLP‑1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controls, pointing to increa ...
EurekAlert!

[Research Article] Evaluating the quality of VGI and authoritative data in red-crowned crane conservation: a comparative study

A new study published in Big Earth Data systematically evaluates the data quality of Volunteered Geographic Information (VGI) ...

Positive Clinical Results from HyBryte(TM) Comparative Study Evaluating HyBryte(TM) Against Valchlor(R) in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Comparative Study: NVIDIA And Industry Competitors In Semiconductors & Semiconductor Equipment Industry

Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health ...

Comparative Study: Tesla And Industry Competitors In Automobiles Industry

Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health ...
ascopubs.org

Comparative study of prognosis of conversion therapy vs palliative therapy without surgery in colorectal cancer with synchronous liver metastasis according to risk classifications.

A phase 1 study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients (pts) with advanced solid tumors including colorectal cancer: Updated dose-escalation part. Survival ...

SOLIGENIX, INC.: Positive Clinical Results from HyBryte Comparative Study Evaluating HyBryte Against Valchlor in the Treatment of Cutaneous T-Cell Lymphoma Published in ...

HyBryte demonstrates more rapid and robust treatment response compared toValchlor® during 12-week treatment course PRINCETON, N.J., April 2, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ...